SCHEMBL3379747

SCHEMBL3379747

CC1(C(=O)O)COc2ccc(O)cc2O1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.44
MAPT P10636 3/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 1/20 0.41
TMEM97 Q5BJF2 2/20 0.39
HTR2B P41595 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
NPC1L1 Q9UHC9 1/20 0.35
HIF1A Q16665 1/20 0.35
EPAS1 Q99814 1/20 0.35
PTPN1 P18031 1/20 0.35
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
XDH P47989 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13069646 0.84 CYP3A4 (0.41) CYP3A4MAPTALDH1A1KDM4ETMEM97
SCHEMBL13070037 0.84 CYP3A4 (0.41) CYP3A4MAPTALDH1A1KDM4ETMEM97
SCHEMBL3518175 0.83 NPC1 (0.41) MAPTNPC1RAB9ATP53NPSR1
SCHEMBL1986826 0.80 ALOX15 (0.44) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL10335043 0.80 AKR1B1 (0.45) MAPTALDH1A1NPC1RAB9AMAPK1
Hydrochloric Acid SCHEMBL10335958 0.79 ALOX15 (0.43) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL4382214 0.78 CYP3A4 (0.41) CYP3A4MAPTALDH1A1KDM4ETMEM97
SCHEMBL10334288 0.78 AKR1B1 (0.40) NPC1RAB9AHPGDCYP1A2CYP2C19
SCHEMBL3518868 0.77 NPC1 (0.41) MAPTNPC1RAB9ATP53NPSR1
SCHEMBL23618118 0.76 PPARA (0.47) CYP3A4MAPTALDH1A1KDM4EHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1796665-B1 COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS MERCK SHARP & DOHME (US) 2010-11-17 EP disclosed
EP-1796665-A4 COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS MERCK & CO INC (US) 2009-08-12 EP disclosed
EP-1796665-A2 COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS Merck & Co., Inc. (US) 2007-06-20 EP disclosed
WO-2006033891-A2 COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS MERCK & CO., INC. (US) 2006-03-30 WO disclosed